Unknown

Dataset Information

0

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness.


ABSTRACT: The use of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases. Among the different strategies available, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most robust approaches due to their immune regulatory properties, which are currently being tested in clinical trials. However, the mechanisms that vitD3-tolDC trigger for the induction of tolerance remain elusive. For this reason, we performed a full phenotypical, functional, and transcriptomic characterization of T cells upon their interaction with autologous, antigen-specific vitD3-tolDC. We observed a strong antigen-specific reduction of T cell proliferation, combined with a decrease in the relative prevalence of TH1 subpopulations and IFN-? production. The analysis of the transcriptomic profile of T CD4+ cells evidenced a significant down-modulation of genes involved in cell cycle and cell response to mainly pro-inflammatory immune-related stimuli, highlighting the role of JUNB gene as a potential biomarker of these processes. Consequently, our results show the induction of a strong antigen-specific hyporesponsiveness combined with a reduction on the TH1 immune profile of T cells upon their interaction with vitD3-tolDC, which manifests the regulatory properties of these cells and, therefore, their therapeutic potential in the clinic.

SUBMITTER: Navarro-Barriuso J 

PROVIDER: S-EPMC7856150 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4<sup>+</sup> Cells Towards a Functional Hyporesponsiveness.

Navarro-Barriuso Juan J   Mansilla María José MJ   Quirant-Sánchez Bibiana B   Teniente-Serra Aina A   Ramo-Tello Cristina C   Martínez-Cáceres Eva M EM  

Frontiers in immunology 20210120


The use of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases. Among the different strategies available, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most robust approaches due to their immune regulatory properties, which are currently being tested in clinical trials. However, the mechanisms that vitD3-tolDC trigger for the induction of tolerance remain elusive. For this reason, we p  ...[more]

Similar Datasets

| S-EPMC6175832 | biostudies-literature
| S-EPMC8698295 | biostudies-literature
| S-EPMC8305050 | biostudies-literature
2024-12-13 | GSE267576 | GEO
| S-EPMC6598738 | biostudies-literature
2020-12-21 | GSE128816 | GEO
2024-12-13 | GSE267660 | GEO
2018-07-31 | E-MTAB-6937 | biostudies-arrayexpress
| S-EPMC9740551 | biostudies-literature
| S-EPMC8715888 | biostudies-literature